Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients

Resultado final

Promotional and educational material for stakeholders

Promotional and educational material for stakeholders.

Scientific articles for peer-reviewed journals

Scientific articles for peer-reviewed journals.

Publicaciones

Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma

Autores: Erik H. van Beers, Daphne Huigh, Lizanne Bosman, Leonie de Best, Rowan Kuiper, Marieke Spaan, Mark van Duin, Pieter Sonneveld, Belinda Dumee, Martin H. van Vliet
Publicado en: The Journal of Molecular Diagnostics, Edición Online ahead of print., 2020, Página(s) Online ahead of print., ISSN 1525-1578
Editor: American Society for Investigative Pathology
DOI: 10.1016/j.jmoldx.2020.10.010

Prognostic and Predictive Performance of SKY92 Combined with R-ISS in Elderly Multiple Myeloma Patients in The Hovon-87/NMSG-18 Study

Autores: Rowan Kuiper, Annemiek Broijl, Mark van Duin, Martin H. van Vliet, Mark-David Levin, Erik H. van Beers, Bronno Van der Holt, Heleen Visser, Markus Hansson, Annette W.G. van der Velden, Belinda Dumee, Michael Vermeulen, Jasper Koenders, H. Berna Beverloo, Marian Stevens-Kroef, Pieter Sonneveld, Anders Waage, Sonja Zweegman
Publicado en: Clinical Lymphoma Myeloma and Leukemia, Edición 19/10, 2019, Página(s) e10-e11, ISSN 2152-2650
Editor: Elsevier
DOI: 10.1016/j.clml.2019.09.014

Resultado final

Publicaciones

Compartir esta página

Descargar